CJC-1295 DAC 2mg dosage explained: typical research protocols, reconstitution math, frequency, and how it compares to 5mg vials and no-DAC versions.
CJC-1295 DAC is not approved by the FDA for human use, and there is no officially recognized human dosage for a 2mg vial. In research settings, a 2mg vial is typically reconstituted with bacteriostatic water and dosed in micrograms, with common protocols ranging from 1 mg to 2 mg per week. This article explains the math, frequency, and comparisons researchers use when studying this peptide.
What Is CJC-1295 DAC?
CJC-1295 DAC is a growth hormone-releasing hormone (GHRH) analog. The "DAC" stands for Drug Affinity Complex, which binds to albumin in the blood and extends the peptide's half-life to roughly 6–8 days.
This long half-life is why CJC-1295 DAC is often studied with once-weekly or twice-weekly injections. It is sold strictly as a research chemical, not as a supplement or medication.
Researchers often compare the cjc-1295 with dac 2mg dosage to shorter-acting alternatives when designing studies. The extended action means fewer injections, but it also makes precise dose timing less flexible.
How to Reconstitute a 2mg CJC-1295 DAC Vial
Reconstitution is the first step in any research protocol. You add bacteriostatic water (BAC water) to the lyophilized powder, then draw the desired dose with an insulin syringe.
Common BAC water volumes for a 2mg vial are 1 mL, 2 mL, or 3 mL. The concentration changes with each volume, which directly affects how many units you draw.
| BAC Water Added | Concentration | 100 mcg | 250 mcg | 500 mcg | 1 mg |
|---|---|---|---|---|---|
| 1 mL | 2 mg/mL | 5 units | 12.5 units | 25 units | 50 units |
| 2 mL | 1 mg/mL | 10 units | 25 units | 50 units | 100 units |
| 3 mL | 0.67 mg/mL | 15 units | 37.5 units | 75 units | 150 units |
Always use sterile technique and store reconstituted peptide in the refrigerator. Do not assume a "unit" is the same across syringe brands; U-100 syringes are standard.
Typical CJC-1295 DAC 2mg Dosage in Research
There is no universal dose, but published research and online discussions often mention 1 mg to 2 mg per week. A common approach is 1 mg twice weekly, or 2 mg once weekly.
Some protocols split the weekly dose into smaller injections to reduce peak effects. Others use a single weekly injection for convenience.
A standard cjc-1295 with dac dosage might be 1 mg every 5–7 days, while a more aggressive research protocol could use 2 mg weekly. These are not medical recommendations.
When comparing a 2mg vial to a 5mg vial, the cjc-1295 with dac 5mg dosage is simply scaled up. The same concentration math applies; you just have more total peptide.
CJC-1295 DAC vs CJC-1295 No DAC Dosage
CJC-1295 without DAC has a much shorter half-life, around 30 minutes. That difference changes dosing frequency and total weekly amount.
The cjc-1295 no dac dosage is usually 100 mcg to 200 mcg per injection, often given 2–3 times daily. This is very different from the long-acting DAC version.
| Version | Half-Life | Typical Research Dose | Frequency |
|---|---|---|---|
| CJC-1295 DAC | 6–8 days | 1–2 mg per week | 1–2x weekly |
| CJC-1295 No DAC | ~30 minutes | 100–200 mcg | 2–3x daily |
| CJC-1295 DAC 2mg vial | 6–8 days | 1–2 mg per week | 1–2x weekly |
| CJC-1295 DAC 5mg vial | 6–8 days | 1–2 mg per week | 1–2x weekly |
Many forum posts share anecdotal experiences, but these are not clinical evidence. They can vary widely and should be treated as personal experiences, not guidelines.
CJC-1295 DAC and Ipamorelin Stack Dosage
CJC-1295 DAC is sometimes studied alongside ipamorelin, a ghrelin mimetic. The idea is to combine two pathways that stimulate growth hormone release.
Some protocols use a cjc-1295 no dac ipamorelin 10mg blend dosage, which typically contains 5mg of each peptide in a 10mg vial. That blend is dosed differently from a pure CJC-1295 DAC vial.
If you are researching a stack, keep the CJC-1295 DAC weekly dose separate from the ipamorelin dose. Do not mix up the math between a 2mg single-peptide vial and a 10mg blend.
Safety, Side Effects, and Legal Status
CJC-1295 DAC is not FDA-approved for human use in the United States. It is sold for laboratory research only, and human consumption is not recommended.
Reported side effects in anecdotal reports include injection-site irritation, flushing, headache, and changes in blood sugar or appetite. These are not established from controlled trials.
Anyone considering any peptide should consult a licensed healthcare professional. Self-dosing with research chemicals carries serious risks, including unknown purity, dosing errors, and unmonitored side effects.
Key Takeaways
- A 2mg CJC-1295 DAC vial is a quantity, not a dose; the dose depends on how much BAC water you add.
- Common research protocols use 1–2 mg per week, often split into 1–2 injections.
- CJC-1295 no DAC requires much more frequent dosing because of its short half-life.
- CJC-1295 DAC is not FDA-approved for human use, and research use only is the legal and labeled purpose.
Frequently Asked Questions
How much BAC water should I add to a 2mg CJC-1295 DAC vial?
There is no single correct volume. Researchers commonly add 1 mL, 2 mL, or 3 mL of bacteriostatic water. Adding 1 mL gives 2 mg/mL, 2 mL gives 1 mg/mL, and 3 mL gives about 0.67 mg/mL. The right choice depends on the dose size you want to draw.
What is a typical CJC-1295 DAC 2mg dosage per week?
In research settings, common weekly totals are 1 mg to 2 mg. That might be 1 mg twice weekly or 2 mg once weekly. No human dosage is FDA-approved, and these numbers come from research protocols and anecdotal reports, not clinical guidelines.
Is CJC-1295 DAC the same as CJC-1295 no DAC?
No. CJC-1295 DAC has a Drug Affinity Complex that extends its half-life to about 6–8 days. CJC-1295 no DAC has a half-life of roughly 30 minutes and is usually dosed multiple times daily. They are not interchangeable.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.